Why the study?
Pluripotent stem cell differentiation into a heterogeneous cardiomyocyte population increases post-transplantation arrhythmia risk, prompting the need for protocols driving a ventricular lineage.
Population
Mouse embryonic stem cells cultured in monolayers or three-dimensional hanging drop method
Comparison
Different treatments acting on Wnt and retinoic acid signalling
Design
In vitro experimental study
Authors
Loading...
May lower post-transplant arrhythmia risk in preclinical PSC models; leaves open human translation and efficacy trials.
In vitro regulation of Wnt and retinoic acid signaling pathways directs mouse embryonic stem cells to differentiate into ventricular-specific cardiomyocytes.
Satthenapalli et al. (2022) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: